Cdc20 and Securin Overexpression Predict Short-term Breast Cancer Survival

Overview

Journal Br J Cancer

Specialty Oncology

Date 2014 May 24

PMID 24853182

Citations 90

Authors

H Karra

H Repo

I Ahonen

E Loyttyniemi

R Pitkanen

M Lintunen

T Kuopio

M Soderstrom

P Kronqvist

Affiliations

Soon will be listed here.

Abstract

Background: Cdc20 is an essential component of cell division and responsible for anaphase initiation regulated by securin degradation. Cdc20 function is strongly regulated by the spindle assembly checkpoint to ensure the timely separation of sister chromatids and integrity of the genome. We present the first results on Cdc20 in a large clinical breast cancer material.

Methods: The study was based on 445 breast cancer patients with up to 20 years of follow-up (mean 10.0 years). DNA content was determined by image cytometry on cell imprints, and Cdc20 and securin immunohistochemistry on tissue microarrays of breast cancer tissue.

Results: In our results, high Cdc20 and securin expression was associated with aneuploid DNA content. In prognostic analyses, high Cdc20 immunoexpression alone and in combination with high securin immunoexpression indicated aggressive course of disease and up to 6.8-fold (P<0.001) risk of breast cancer death. Particularly, high Cdc20 and securin immunoexpression identified a patient subgroup with extremely short, on average 2.4 years, breast cancer survival and triple-negative breast cancer (TNBC) subtype.

Conclusions: We report for the first time the association of high Cdc20 and securin immunoexpression with extremely poor outcome of breast cancer patients. Our experience indicates that Cdc20 and securin are promising candidates for clinical applications in breast cancer prognostication, especially in the challenging prognostic decisions of TNBC.

Citing Articles

High CDC20 levels increase sensitivity of cancer cells to MPS1 inhibitors.

Zheng S, Raz L, Zhou L, Cohen-Sharir Y, Tian R, Ippolito M EMBO Rep. 2025; 26(4):1036-1061.

PMID: 39838194 PMC: 11850905. DOI: 10.1038/s44319-024-00363-8.

CDC20 and CCNB1 Overexpression as Prognostic Markers in Bladder Cancer.

Sevim Nalkiran H, Biri I, Nalkiran I, Uzun H, Durur S, Bedir R Diagnostics (Basel). 2025; 15(1.

PMID: 39795587 PMC: 11719780. DOI: 10.3390/diagnostics15010059.

Prognostic and Therapeutic Implications of Cell Division Cycle 20 Homolog in Breast Cancer.

Messeha S, Zarmouh N, Maku H, Gendy S, Yedjou C, Elhag R Cancers (Basel). 2024; 16(14.

PMID: 39061186 PMC: 11274456. DOI: 10.3390/cancers16142546.

Antitumor Effect of Apcin on Endometrial Carcinoma via p21-Mediated Cell Cycle Arrest and Apoptosis.

Ni K, Li Z, Hu Z, Hong L Curr Med Sci. 2024; 44(3):623-632.

PMID: 38853192 DOI: 10.1007/s11596-024-2877-z.

HOXD8 suppresses renal cell carcinoma growth by upregulating SHMT1 expression.

Yang Y, Zhang M, Zhao Y, Deng T, Zhou X, Qian H Cancer Sci. 2023; 114(12):4583-4595.

PMID: 37752684 PMC: 10728000. DOI: 10.1111/cas.15982.

References

Taniguchi K, Momiyama N, Ueda M, Matsuyama R, Mori R, Fujii Y . Targeting of CDC20 via small interfering RNA causes enhancement of the cytotoxicity of chemoradiation. Anticancer Res. 2008; 28(3A):1559-63. View

Panguluri S, Yeakel C, Kakar S . PTTG: an important target gene for ovarian cancer therapy. J Ovarian Res. 2008; 1(1):6. PMC: 2584053. DOI: 10.1186/1757-2215-1-6. View

Perou C, Sorlie T, Eisen M, van de Rijn M, Jeffrey S, Rees C . Molecular portraits of human breast tumours. Nature. 2000; 406(6797):747-52. DOI: 10.1038/35021093. View

Kumada K, Nakamura T, Nagao K, Funabiki H, Nakagawa T, Yanagida M . Cut1 is loaded onto the spindle by binding to Cut2 and promotes anaphase spindle movement upon Cut2 proteolysis. Curr Biol. 1998; 8(11):633-41. DOI: 10.1016/s0960-9822(98)70250-7. View

Goldhirsch A, Wood W, Coates A, Gelber R, Thurlimann B, Senn H . Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011; 22(8):1736-47. PMC: 3144634. DOI: 10.1093/annonc/mdr304. View

Thirthagiri E, Robinson C, Huntley S, Davies M, Yap L, Prime S . Spindle assembly checkpoint and centrosome abnormalities in oral cancer. Cancer Lett. 2007; 258(2):276-85. DOI: 10.1016/j.canlet.2007.09.008. View

Sorlie T, Perou C, Tibshirani R, Aas T, Geisler S, Johnsen H . Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001; 98(19):10869-74. PMC: 58566. DOI: 10.1073/pnas.191367098. View

Li M, Fang X, Wei Z, York J, Zhang P . Loss of spindle assembly checkpoint-mediated inhibition of Cdc20 promotes tumorigenesis in mice. J Cell Biol. 2009; 185(6):983-94. PMC: 2711613. DOI: 10.1083/jcb.200904020. View

Jensen S, Segal M, Clarke D, Reed S . A novel role of the budding yeast separin Esp1 in anaphase spindle elongation: evidence that proper spindle association of Esp1 is regulated by Pds1. J Cell Biol. 2001; 152(1):27-40. PMC: 2193664. DOI: 10.1083/jcb.152.1.27. View

10.

Jiang J, Thyagarajan-Sahu A, Krchnak V, Jedinak A, Sandusky G, Sliva D . NAHA, a novel hydroxamic acid-derivative, inhibits growth and angiogenesis of breast cancer in vitro and in vivo. PLoS One. 2012; 7(3):e34283. PMC: 3315582. DOI: 10.1371/journal.pone.0034283. View

11.

Chiorean R, Braicu C, Berindan-Neagoe I . Another review on triple negative breast cancer. Are we on the right way towards the exit from the labyrinth?. Breast. 2013; 22(6):1026-33. DOI: 10.1016/j.breast.2013.08.007. View

12.

Talvinen K, Tuikkala J, Nevalainen O, Rantanen A, Hirsimaki P, Sundstrom J . Proliferation marker securin identifies favourable outcome in invasive ductal breast cancer. Br J Cancer. 2008; 99(2):335-40. PMC: 2480969. DOI: 10.1038/sj.bjc.6604475. View

13.

Sotiriou C, Neo S, McShane L, Korn E, Long P, Jazaeri A . Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A. 2003; 100(18):10393-8. PMC: 193572. DOI: 10.1073/pnas.1732912100. View

14.

Jallepalli P, Lengauer C . Chromosome segregation and cancer: cutting through the mystery. Nat Rev Cancer. 2002; 1(2):109-17. DOI: 10.1038/35101065. View

15.

Weinstein J, Jacobsen F, Wu T, Baum L . A novel mammalian protein, p55CDC, present in dividing cells is associated with protein kinase activity and has homology to the Saccharomyces cerevisiae cell division cycle proteins Cdc20 and Cdc4. Mol Cell Biol. 1994; 14(5):3350-63. PMC: 358701. DOI: 10.1128/mcb.14.5.3350-3363.1994. View

16.

Kim D, Franklyn J, Smith V, Stratford A, Pemberton H, Warfield A . Securin induces genetic instability in colorectal cancer by inhibiting double-stranded DNA repair activity. Carcinogenesis. 2006; 28(3):749-59. DOI: 10.1093/carcin/bgl202. View

17.

Tfelt-Hansen J, Kanuparthi D, Chattopadhyay N . The emerging role of pituitary tumor transforming gene in tumorigenesis. Clin Med Res. 2006; 4(2):130-7. PMC: 1483889. DOI: 10.3121/cmr.4.2.130. View

18.

Kim S, Yu H . Mutual regulation between the spindle checkpoint and APC/C. Semin Cell Dev Biol. 2011; 22(6):551-8. PMC: 3225258. DOI: 10.1016/j.semcdb.2011.03.008. View

19.

Mondal G, Sengupta S, Panda C, Gollin S, Saunders W, Roychoudhury S . Overexpression of Cdc20 leads to impairment of the spindle assembly checkpoint and aneuploidization in oral cancer. Carcinogenesis. 2006; 28(1):81-92. DOI: 10.1093/carcin/bgl100. View

20.

Cho-Rok J, Yoo J, Jang Y, Kim S, Chu I, Yeom Y . Adenovirus-mediated transfer of siRNA against PTTG1 inhibits liver cancer cell growth in vitro and in vivo. Hepatology. 2006; 43(5):1042-52. DOI: 10.1002/hep.21137. View